Home >> Signaling Pathways >> Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Products for  Immunology/Inflammation

  1. Cat.No. 产品名称 Information
  2. GC52355 BimS BH3 (51-76) (human) (trifluoroacetate salt)

    DMRPEIWIAQELRRIGDEFNAYYARR-OH, Bims (51-76)

    A Bim-derived peptide
  3. GC52351 Citrullinated α-Enolase (R8 + R14) (1-19)-biotin Peptide

    Citrullinated Enolase-1-biotin, α-Enolase Peptide (Citrulline Residues 8 + 14)

    A biotinylated and citrullinated α-enolase peptide
  4. GC52346 IDR 1002 (trifluoroacetate salt) A synthetic cationic innate defense regulator peptide
  5. GC52344 Bak BH3 (72-87) (human) (trifluoroacetate salt) A Bak-derived peptide
  6. GC52343 113-O12B An ionizable cationic lipidoid
  7. GC52342 P4pal10 (trifluoroacetate salt)

    Palmitoyl-SGRRYGHALR-amide, Palmitoyl-SGRRYGHALR-NH2

    A PAR4 and FPR2 antagonist and an FFAR2 agonist
  8. GC52334 ENPP1 Inhibitor 4e

    cGAMP-compound 4e

    An ENPP1 inhibitor
  9. GC52332 Arimoclomol

    BRX-220

    A co-inducer of heat shock proteins
  10. GC52329 Betamethasone-d5

    β-Methasone-d5, SCH 4831-d5

    An internal standard for the quantification of betamethasone
  11. GC52326 Biotin-PEG4-LL-37 (human) (trifluoroacetate salt) A biotinylated and pegylated form of LL-37
  12. GC52324 3-(3-Hydroxyphenyl)propionic Acid sulfate

    3-HPPA sulfate

    A metabolite of certain phenols and glycosides
  13. GC52323 L-Isoleucine-13C6

    L-(+)-Isoleucine-13C6

    An internal standard for the quantification of L-isoleucine
  14. GC52321 ISP-I-28 An immunosuppressant
  15. GC52318 Oleic Acid-13C5

    9Z-Octadecenoic Acid-13C5, C18:1(9Z)-13C5, cis-9-Octadecenoic Acid-13C5

    An internal standard for the quantification of oleic acid
  16. GC52307 CAY10790 A CysLT1 receptor antagonist and GPBAR1 agonist
  17. GC52306 Pentadecanoyl-L-carnitine (chloride)

    CAR 15:0, C15:0 Carnitine, L-Carnitine pentadecanoyl ester, L-Pentadecanoylcarnitine

    A CB receptor agonist
  18. GC52303 Ethyl Mycophenolate A potential impurity found in commercial preparations of mycophenolate mofetil
  19. GC52293 STAT3 Inhibitor 4m

    Signal Transducer and Activator of Transcription 3 Inhibitor 4m

    A STAT3 inhibitor
  20. GC52291 KAS 08 A STING activator
  21. GC52288 Fumonisin B1-13C34

    FB1-13C34

    An internal standard for the quantification of fumonisin B1
  22. GC52283 L-Cysteine-15N-d3

    L-Cys-15N-d3, L-(+)-Cysteine-15N-d3, (R)-Cysteine-15N-d3

    An internal standard for the quantification of L-cysteine
  23. GC52274 Y-33075 (hydrochloride)

    RKI-983, SNJ-1656, Y-39983

    An inhibitor of ROCK2
  24. GC52270 Pranoprofen-13C-d3

    Pyranoprofen-13C-d3, Y 8004-13C-d3

    An internal standard for the quantification of pranoprofen
  25. GC52269 Cinnabarinic Acid-d4 An internal standard for the quantification of cinnabarinic acid
  26. GC52261 Entecavir-d2 An internal standard for the quantification of entecavir
  27. GC52253 α-Enolase (1-19)-biotin Peptide

    Enolase-1 (1-19)-biotin

    A biotinylated α-enolase peptide
  28. GC52245 CAY10792 An anticancer agent
  29. GC52240 BPH-1358

    NSC 50460

    An inhibitor of UPPS and FPPS
  30. GC52227 5-(3',4'-Dihydroxyphenyl)-γ-Valerolactone

    (±)-δ-(3,4-Dihydroxyphenyl)-γ-Valerolactone, 5-(3',4'-Dihydroxyphenyl)-γ-VL

    An active metabolite of various polyphenols
  31. GC52211 7-[1-(1H)-Tetrazolylacetamido]desacetoxycephalosporanic Acid

    Cefazolin Impurity H

    A potential impurity in commercial preparations of cefazolin
  32. GC20109 Cefotiam hexetil hydrochloride

    盐酸头孢替安酯; CTM-HE hydrochloride; SCE-2174 hydrochloride

    Cefotiam hexetil hydrochloride 是可口服的第三代头孢菌素,是 cefotiam 的前药,但无抗菌作用。Cefotiam 是一种抗生素。

  33. GC20095 5,7-Dihydroxy-4-methylcoumarin

    NSC 5302

    A synthetic coumarin with diverse biological activities
  34. GC20091 α-Arbutin

    α-熊果苷; 4-Hydroxyphenyl α-D-glucopyranoside

    A glycosylated hydroquinone with diverse biological activities
  35. GC67628 2',7'-Dichlorofluorescein

    2',7'-二氯荧光素;二氯荧光黄;二氯荧光素;2,7-二氯-3,6-萤烷二醇;2,7-二氯荧光黄

    2',7'-Dichlorofluorescein是一种荧光探针,可用于测量活性氧 (ROS) (Ex=496 nm 和 Em=525 nm)。
  36. GC67618 α-Tocopherol phosphate disodium

    alpha-Tocopherol phosphate disodium; TocP disodium; Vitamin E phosphate disodium

    α-Tocopherol phosphate (alpha-Tocopherol phosphate) 是一种抗氧化剂,可以保护长波 UVA1 诱导的细胞死亡,并清除 UVA1 诱导的活性氧 (ROS)。α-Tocopherol phosphate disodium 可抑制内皮祖细胞凋亡 (apoptosis),增加高糖/低氧条件下内皮祖细胞迁移能力,促进血管生成。
  37. GC67272 N6-Benzyladenosine

    Benzyladenosine

    DNPH1i (N6-benzyladenosine,BAPR) is a competitive inhibitor of adenosine deaminase(ADA) from L-1210 cells in axenic culture as well as a potent antiproliferative agent in vitro and in vivo.
  38. GC67214 Emoxypine succinate

    美昔得乐琥珀酸盐

    Emoxypine succinate 是一种抗氧化剂。 Emoxypine succinate 可用于创伤后的研究。
  39. GC67191 (±)-α-Tocopherol nicotinate (±)-α-Tocopherol nicotinate,维生素 E-烟酸酯,是一种具有口服活性的脂溶性抗氧化剂,能够防止细胞膜脂质过氧化。(±)-α-Tocopherol nicotinate 在血液中可水解为 α -生育酚和烟酸,可用于相关血管疾病的研究。
  40. GC66874 N-((Allyloxy)carbonyl)-N-methyl-L-alanine N-((Allyloxy)carbonyl)-N-methyl-L-alanine 是一种丙氨酸衍生物。N-((Allyloxy)carbonyl)-N-methyl-L-alanine 可用于合成补体因子D (complement factor D) 抑制剂。补体因子 D 抑制剂可用于免疫系统相关疾病的研究。
  41. GC66870 β-D-Glucan β-D-glucan 是一种天然的不易消化的多糖,具有很高的生物相容性,可被识别受体,如 Dectin-1 和 Toll 样受体选择性识别,并容易被鼠或人巨噬细胞内化。β-D-glucan 是益生菌的肠道输送载体。
  42. GC66824 D-α-Tocopherol Succinate

    Vitamin E succinate

    D-α-Tocopherol Succinate (Vitamin E succinate) 是一种抗氧化生育酚,是维生素 E 的一种盐形式。D-α-Tocopherol Succinat 抑制 Cisplatin 引起的毒性。D-α-Tocopherol Succinate 可用于癌症的研究。
  43. GC66485 Bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl] oxalate Bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl] oxalate 是一种活性较高的过草酸酯,可用于荧光染料检测H2O2。
  44. GC66478 LHC-165 LHC-165 是一种有效的 Toll 样受体 7 (TLR7)) 激动剂。LHC-165 有研究实体肿瘤的潜力。
  45. GC66462 MGH-CP1 MGH-CP1 is a potent and selective inhibitor of transcriptional enhanced associate domain (TEAD) palmitoylation. MGH-CP1 exhibits dose-dependent and potent inhibition of TEAD2/4 auto-palmitoylation in vitro with IC50 of 710 nM and 672 nM, respectively.
  46. GC66414 Sarilumab

    Anti-Human IL6Rα, Human Antibody

    Sarilumab (anti-IL-6Rα) is a fully human anti-IL-6Rα mAb that binds membrane-bound and soluble human IL-6Rα with high affinity, MW: 144.13 KD.

  47. GC66410 Cemdisiran

    ALN-CC5

    Cemdisiran是一种 GalNAc 偶联的 siRNA干扰,通过抑制肝脏补体5 (C5)蛋白的产生来治疗补体介导的疾病。
  48. GC66407 Etokimab

    Antibody ANB 020

    Etokimab (Antibody ANB 020) 是一种靶向 IL-33 的人源化单克隆抗体。Etokimab 可用于特应性皮炎的研究。

  49. GC66396 Agatolimod

    ODN 2006; CpG 7909; PF-3512676

    Agatolimod (ODN 2006) 为 B 类 ODN (寡脱氧核苷酸),是一种 TLR9 激动剂。Agatolimod 也是人类最优的 CpG 序列。Agatolimod 刺激 HD11 细胞产生 NO2 和 IL-6。Agatolimod 可用于乳腺癌研究。序列:5'-tcgtcgttttgtcgttttgtcgtt-3'。
  50. GC66393 ODN 1018

    1018 ISS

    ODN 1018 (1018 ISS) 是一种寡脱氧核苷酸,是一种 TLR-9 激动剂。 ODN 1018 也是一种合成的免疫刺激序列,可用作疫苗佐剂。序列:5′-TGACTGTGAACGTTCGAGATGA-3′。
  51. GC66392 PROTAC STING Degrader-1 PROTAC STING Degrader-1 (Compound SP23) 是一种 STING PROTAC 降解剂,其 DC50 为 3.2 μM。PROTAC STING Degrader-1 具有抗炎活性。

Items 801 to 850 of 4267 total

per page

Set Descending Direction